Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION
No-Receipt date
2002-04585 - 29/11/2002
No-Filing date
20020404046 - 29/11/2002
No-Granting date
3041781 - 29/11/2002
No-EPO application date
99931313.3 - 18/06/1999
No-EPO granting date
1089737 - 16/10/2002
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2002 - 19/12/2002
Expiration date
19/06/2019
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
FI98147325/06/1998/FI
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/50
A61P 9/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
210635
ORION CORPORATION (I ORION OYJ), ME ARITHMO MITROOU EPICHEIRISEON 1999212-6
ORIONINTIE,
ESPOO
02200
FINLAND
Inventors
Code
Firstname
Surname
163763
LEHTONEN, LASSE
Representatives
Code
Firstname
Surname
Address
Town
Zip
745
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2126
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
30/03/2007
Μεταβίβαση (7e802)
Αρ. πρωτ. 1256/ 21-2-2007, κωδ. πληρεξ. 745
108397 ORION CORPORATION Orionintie 1 ΦΙΝΛΑΝΔΙΑ 02200 Espoo
210635 Orion Corporation (ή Orion OYJ), με αριθμό Μητρώου Επιχειρήσεων 1999212-6 Orionintie, ΦΙΝΛΑΝΔΙΑ Espoo
Title Instruments
Date
Operation
Descreption
1/3/2014 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 12/2013, Αρ. πρωτ. Γ.Δ. 2/3.1.2014
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).